This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miao, G G
Right arrow Articles by Curran, T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miao, G G
Right arrow Articles by Curran, T

 Previous Article  |  Next Article 

Mol Cell Biol. 1994 June; 14(6): 4295-4310

Cell transformation by c-fos requires an extended period of expression and is independent of the cell cycle.

G G Miao and T Curran

Roche Institute of Molecular Biology, Nutley, New Jersey 07110.

ABSTRACT

The proto-oncogene transcription factors Fos and Jun form a heterodimeric complex that binds to DNA and regulates expression of specific target genes. Continuous expression of c-fos causes transformation of cultured fibroblasts and induces osteogenic sarcoma in mice. To investigate the molecular basis of fos-mediated oncogenesis, we developed a conditional cell transformation system in which Fos expression was regulated by isopropyl-beta-D-thiogalactopyranoside (IPTG). Synthesis or repression of Fos in L1-3c-fos cells occurred rapidly, within 30 min, after the removal or addition of IPTG to the culture medium. However, there was a significant delay between the induction of Fos expression and the appearance of morphological transformation. No effect was observed after 12 h of Fos expression, partial transformation was detected after 24 h, and full transformation required approximately 3 days of continuous Fos expression. Similarly, the transformed cell morphology persisted for at least 2 days after repression of Fos, and a normal phenotype was observed only after 3 days. Fos-Jun complexes, capable of binding to AP-1 sequences, were present continuously during the delay in morphological transformation. Furthermore, increased expression of several candidate Fos target genes, including those encoding Fra-1, transin (stromelysin), collagenase, and ornithine decarboxylase, was detected shortly after Fos induction. The induction of morphological transformation was not dependent on the cell cycle, as it occurred in both cycling and noncycling cells. Thus, the Fos-Jun complexes present before L1-3c-fos cells become fully transformed are transcriptionally active. These complexes disappeared, and the Fos target genes were repressed at least 2 days prior to reversion. Our results suggest that cell transformation by Fos requires increased expression of a target gene(s) with a long-lived product(s) that must reach a critical level.


Mol Cell Biol. 1994 June; 14(6): 4295-4310




This article has been cited by other articles:

  • Spence, H. J., McGarry, L., Chew, C. S., Carragher, N. O., Scott-Carragher, L. A., Yuan, Z., Croft, D. R., Olson, M. F., Frame, M., Ozanne, B. W. (2006). AP-1 Differentially Expressed Proteins Krp1 and Fibronectin Cooperatively Enhance Rho-ROCK-Independent Mesenchymal Invasion by Altering the Function, Localization, and Activity of Nondifferentially Expressed Proteins. Mol. Cell. Biol. 26: 1480-1495 [Abstract] [Full Text]  
  • Scott, L. A., Vass, J. K., Parkinson, E. K., Gillespie, D. A. F., Winnie, J. N., Ozanne, B. W. (2004). Invasion of Normal Human Fibroblasts Induced by v-Fos Is Independent of Proliferation, Immortalization, and the Tumor Suppressors p16INK4a and p53. Mol. Cell. Biol. 24: 1540-1559 [Abstract] [Full Text]  
  • Hu, Y.-L., Albanese, C., Pestell, R. G., Jaffe, R. B. (2003). Dual Mechanisms for Lysophosphatidic Acid Stimulation of Human Ovarian Carcinoma Cells. JNCI J Natl Cancer Inst 95: 733-740 [Abstract] [Full Text]  
  • Ordway, J. M., Curran, T. (2002). Methylation Matters: Modeling a Manageable Genome. Cell Growth Differ. 13: 149-162 [Full Text]  
  • Hennigan, R. F., Stambrook, P. J. (2001). Dominant Negative c-jun Inhibits Activation of the Cyclin D1 and Cyclin E Kinase Complexes. Mol. Biol. Cell 12: 2352-2363 [Abstract] [Full Text]  
  • Voelkel-Johnson, C., Voeks, D. J., Greenberg, N. M., Barrios, R., Maggouta, F., Kurtz, D. T., Schwartz, D. A., Keller, G. M., Papenbrock, T., Clawson, G. A., Norris, J. S. (2000). Genomic instability-based transgenic models of prostate cancer. Carcinogenesis 21: 1623-1627 [Abstract] [Full Text]  
  • Thomas, D., Sunters, A, Gentry, A, Grigoriadis, A. (2000). Inhibition of chondrocyte differentiation in vitro by constitutive and inducible overexpression of the c-fos proto-oncogene. J. Cell Sci. 113: 439-450 [Abstract]  
  • Kurschner, C., Yuzaki, M. (1999). Neuronal Interleukin-16 (NIL-16): A Dual Function PDZ Domain Protein. J. Neurosci. 19: 7770-7780 [Abstract] [Full Text]  
  • Okada, S., Fukuda, T., Inada, K., Tokuhisa, T. (1999). Prolonged Expression of c-fos Suppresses Cell Cycle Entry of Dormant Hematopoietic Stem Cells. Blood 93: 816-825 [Abstract] [Full Text]  
  • Bakin, A. V., Curran, T. (1999). Role of DNA 5-Methylcytosine Transferase in Cell Transformation by fos. Science 283: 387-390 [Abstract] [Full Text]  
  • Treinies, I., Paterson, H. F., Hooper, S., Wilson, R., Marshall, C. J. (1999). Activated MEK Stimulates Expression of AP-1 Components Independently of Phosphatidylinositol 3-Kinase (PI3-Kinase) but Requires a PI3-Kinase Signal To Stimulate DNA Synthesis. Mol. Cell. Biol. 19: 321-329 [Abstract] [Full Text]  
  • Cook, S. J., Aziz, N., McMahon, M. (1999). The Repertoire of Fos and Jun Proteins Expressed during the G1 Phase of the Cell Cycle Is Determined by the Duration of Mitogen-Activated Protein Kinase Activation. Mol. Cell. Biol. 19: 330-341 [Abstract] [Full Text]  
  • Malliri, A., Symons, M., Hennigan, R. F., Hurlstone, A. F.L., Lamb, R. F., Wheeler, T., Ozanne, B. W. (1998). The Transcription Factor AP-1 Is Required for EGF-induced Activation of Rho-like GTPases, Cytoskeletal Rearrangements, Motility, and In Vitro Invasion of A431 Cells. JCB 143: 1087-1099 [Abstract] [Full Text]  
  • He, H., Qi, X.-M., Grossmann, J., Distelhorst, C. W. (1998). c-Fos Degradation by the Proteasome. AN EARLY, Bcl-2-REGULATED STEP IN APOPTOSIS. J. Biol. Chem. 273: 25015-25019 [Abstract] [Full Text]  
  • Brown, J. R., Nigh, E., Lee, R. J., Ye, H., Thompson, M. A., Saudou, F., Pestell, R. G., Greenberg, M. E. (1998). Fos Family Members Induce Cell Cycle Entry by Activating Cyclin D1. Mol. Cell. Biol. 18: 5609-5619 [Abstract] [Full Text]  
  • Slotkin, T. A. (1998). Fetal Nicotine or Cocaine Exposure: Which One is Worse?. J. Pharmacol. Exp. Ther. 285: 931-945 [Abstract] [Full Text]  
  • Watanabe, G., Howe, A., Lee, R. J., Albanese, C., Shu, I-W., Karnezis, A. N., Zon, L., Kyriakis, J., Rundell, K., Pestell, R. G. (1996). Induction of cyclin D1 by simian virus 40 small tumor antigen. Proc. Natl. Acad. Sci. USA 93: 12861-12866 [Abstract] [Full Text]  
  • Albanese, C., Johnson, J., Watanabe, G., Eklund, N., Vu, D., Arnold, A., Pestell, R. G. (1995). Transforming p21[IMAGE] Mutants and c-Ets-2 Activate the Cyclin D1 Promoter through Distinguishable Regions. J. Biol. Chem. 270: 23589-23597 [Abstract] [Full Text]